Image via WikipediaMerck gains a defense verdict in the first of many state-court lawsuits in which its Fosamax osteoporosis drug is blamed for causing so-called jaw death.
the Plaintiff was Alison Rosenberg. She argued that she developed osteonecrosis of the jaw, or ONJ.
The jury answered “no” to the first question on the verdict form: Was it more likely than not that Rosenberg had the condition she claimed? The vote was 9 to 1. Because the first answer meant victory for the company, the panel didn’t have to answer three other questions.
Merck has now won defense verdicts in 2 of 3 trials.